Prevalences and associated risk factors of HCV/HIV co-infection and HCV mono-infection among injecting drug users in a methadone maintenance treatment program in Taipei, Taiwan

BMC Public Health

Volumn 12, Issue 1, 2012, Pages

  Yen, Yung Feng ^a,b   Yen, Muh Yong ^a   Su, Lien Wen ^a   Li, Lan Huei ^a   Chuang, Peing ^a   Jiang, Xiao Ru ^a   Deng, Chung Yeh ^b  

^a TAIPEI CITY HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

HCV; HIV; Injection drug use; Methadone; Taiwan

Indexed keywords

METHADONE;

ADULT; ARTICLE; CROSS-SECTIONAL STUDY; DOSE RESPONSE; FEMALE; HEPATITIS C; HEROIN DEPENDENCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTERVIEW; MALE; MIDDLE AGED; MIXED INFECTION; PREVALENCE; PROGRAM EVALUATION; PSYCHOLOGICAL ASPECT; RESIDENTIAL CARE; RISK FACTOR; SUBSTANCE ABUSE; TAIWAN; YOUNG ADULT;

ADULT; COINFECTION; CROSS-SECTIONAL STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HEPATITIS C; HEROIN DEPENDENCE; HIV INFECTIONS; HUMANS; INTERVIEWS AS TOPIC; MALE; METHADONE; MIDDLE AGED; PREVALENCE; PROGRAM EVALUATION; RESIDENTIAL TREATMENT; RISK FACTORS; SUBSTANCE ABUSE, INTRAVENOUS; TAIWAN; YOUNG ADULT;

EID: 84870676068     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/1471-2458-12-1066     Document Type: Article

References (34)

1. Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review. Mathers BM, Degenhardt L, Phillips B, Wiessing L, Hickman M, Strathdee SA, Wodak A, Panda S, Tyndall M, Toufik A, et al. Lancet 2008 372 1733 1745 10.1016/S0140-6736(08)61311-2 18817968
2. Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews. Nelson PK, Mathers BM, Cowie B, Hagan H, Des Jarlais D, Horyniak D, Degenhardt L, Lancet 2011 378 571 583 10.1016/S0140-6736(11)61097-0 21802134
3. Incidence and risk factors for hepatitis C among injection drug users in Baltimore, Maryland. Villano SA, Vlahov D, Nelson KE, Lyles CM, Cohn S, Thomas DL, J Clin Microbiol 1997 35 3274 3277 9399533 (Pubitemid 27505758)
4. Sexual behavior among injection drug users in 3 indonesian cities carries a high potential for HIV spread to noninjectors. Pisani E, Dadun, Sucahya PK, Kamil O, Jazan S, J Acquir Immune Defic Syndr 2003 34 403 406 10.1097/00126334-200312010-00007 14615658 (Pubitemid 37444468)
5. Variability in the incidence of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus infection among young injecting drug users in New York City. Des Jarlais DC, Diaz T, Perlis T, Vlahov D, Maslow C, Latka M, Rockwell R, Edwards V, Friedman SR, Monterroso E, et al. Am J Epidemiol 2003 157 467 471 10.1093/aje/kwf222 12615611 (Pubitemid 36258602)
6. UNAIDS, 2006 Report on the global AIDS epidemic. Geneva: joint UN programme on HIV/AIDS 2006
7. Liver-related deaths in persons infected with the human immunodeficiency virus: the D:A:D study. Weber R, Sabin CA, Friis-Moller N, Reiss P, El-Sadr WM, Kirk O, Dabis F, Law MG, Pradier C, De Wit S, et al. Arch Intern Med 2006 166 1632 1641 16908797 (Pubitemid 44232373)
8. Causes of death among human immunodeficiency virus (HIV)-infected adults in the era of potent antiretroviral therapy: emerging role of hepatitis and cancers, persistent role of AIDS. Lewden C, Salmon D, Morlat P, Bevilacqua S, Jougla E, Bonnet F, Heripret L, Costagliola D, May T, Chene G, Int J Epidemiol 2005 34 121 130 15561752 (Pubitemid 40347381)
9. Hepatitis D virus genotypes in intravenous drug users in taiwan: decreasing prevalence and lack of correlation with hepatitis B virus genotypes. Kao JH, Chen PJ, Lai MY, Chen DS, J Clin Microbiol 2002 40 3047 3049 10.1128/JCM.40.8.3047-3049.2002 12149376 (Pubitemid 35284986)
10. Prevalence of human immunodeficiency virus and its association with hepatitis B, C, and D virus infections among incarcerated male substance abusers in Taiwan. Chu FY, Chiang SC, Su FH, Chang YY, Cheng SH, J Med Virol 2009 81 973 978 10.1002/jmv.21481 19382252
11. Hepatitis C virus infection among short-term intravenous drug users in southern Taiwan. Chang CJ, Lin CH, Lee CT, Chang SJ, Ko YC, Liu HW, Eur J Epidemiol 1999 15 597 601 10.1023/A:1007662315835 10543348 (Pubitemid 29474430)
12. Clinical characteristics and risk behavior as a function of HIV status among heroin users enrolled in methadone treatment in northern Taiwan. Lee TS, Shen HC, Wu WH, Huang CW, Yen MY, Wang BE, Chuang P, Shih CY, Chou YC, Liu YL, Subst Abuse Treat Prev Policy 2011 6 6 10.1186/1747-597X-6-6 21473789
13. Estimation of seroprevalence of hepatitis B virus and hepatitis C virus in Taiwan from a large-scale survey of free hepatitis screening participants. Chen CH, Yang PM, Huang GT, Lee HS, Sung JL, Sheu JC, J Formos Med Assoc 2007 106 148 155 10.1016/S0929-6646(09)60231-X 17339159
14. Taiwan Centers for Disease Control and Prevention, Surveillance of HIV Taipei, Taiwan: CDC http://www.cdc.gov.tw/ [accessed 1 Febrary 2012]. [Chinese]
15. The future face of coinfection: prevalence and incidence of HIV and hepatitis C virus coinfection among young injection drug users. Miller CL, Wood E, Spittal PM, Li K, Frankish JC, Braitstein P, Montaner JS, Schechter MT, J Acquir Immune Defic Syndr 2004 36 743 749 10.1097/00126334-200406010-00012 15167294 (Pubitemid 38685969)
16. Molecular epidemiology of HCV monoinfection and HIV/HCV coinfection in injection drug users in Liuzhou, Southern China. Tan Y, Wei QH, Chen LJ, Chan PC, Lai WS, He ML, Kung HF, Lee SS, PLoS One 2008 3 3608 10.1371/journal.pone. 0003608 18974888
17. Prevalence and correlates of co-infection with human immunodeficiency virus and hepatitis C virus in male injection drug users in Iran. Hosseini M, SeyedAlinaghi S, Kheirandish P, Esmaeli Javid G, Shirzad H, Karami N, Jahani M, Seyed Ahmadian M, Payvarmehr F, Mohraz M, et al. Arch Iran Med 2010 13 318 323 20597566
18. Guidelines for laboratory testing and result reporting of antibody to hepatitis C virus. CDC, MMWR Morb Mortal Wkly Rep 2003 52 1 16 12741579
19. Revised guidelines for HIV counseling, testing, and referral. CfDCa P, MMWR Morb Mortal Wkly Rep 2001 50 1 58 11215787
20. Carbon-monoxide poisoning in young drug addicts due to indoor use of a gasoline-powered generator. Marc B, Bouchez-Buvry A, Wepierre JL, Boniol L, Vaquero P, Garnier M, J Clin Forensic Med 2001 8 54 56 10.1054/jcfm.2001.0474 16083675 (Pubitemid 32591278)
21. Latent tuberculosis among persons at risk for infection with HIV, Tijuana, Mexico. Garfein RS, Laniado-Laborin R, Rodwell TC, Lozada R, Deiss R, Burgos JL, Cuevas-Mota J, Cerecer P, Moser K, Volker ML, et al. Emerg Infect Dis 2010 16 757 763 10.3201/eid1605.091446 20409363
22. Changing seroepidemiology of hepatitis B, C, and D virus infections in high-risk populations. Huo TI, Wu JC, Wu SI, Chang AL, Lin SK, Pan CH, Huang YH, Chang FY, Lee SD, J Med Virol 2004 72 41 45 10.1002/jmv.10554 14635009 (Pubitemid 37484741)
23. Prevalence of antibodies to hepatitis C virus (anti-HCV) in different populations in Taiwan. Wu JS, Lu CF, Liu WT, Lin SY, Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi 1991 24 55 60 1657545
24. Seroprevalence of viral hepatitis and sexually transmitted disease among adults with recently diagnosed HIV infection in Southern Taiwan, 2000-2005: upsurge in hepatitis C virus infections among injection drug users. Lee HC, Ko NY, Lee NY, Chang CM, Ko WC, J Formos Med Assoc 2008 107 404 411 10.1016/S0929-6646(08)60106-0 18492625 (Pubitemid 351803475)
25. Review of HIV and HCV infection among drug users in China. Bao YP, Liu ZM, Lu L, Curr Opin Psychiatry 2010 23 187 194 10.1097/YCO.0b013e328338658b 20308901
26. Prevalence of HIV and hepatitis C virus infections among inmates of Ontario remand facilities. Calzavara L, Ramuscak N, Burchell AN, Swantee C, Myers T, Ford P, Fearon M, Raymond S, CMAJ 2007 177 257 261 10.1503/cmaj.060416 17664449 (Pubitemid 47228218)
27. The risk of HIV and HCV infections among injection drug users in northeast India. Mahanta J, Borkakoty B, Das HK, Chelleng PK, AIDS Care 2009 21 1420 1424 10.1080/09540120902862584 20024719
28. Systematic review of HIV and HCV infection among drug users in China. Bao YP, Liu ZM, Int J STD AIDS 2009 20 399 405 10.1258/ijsa.2008.008362 19451325
29. Prevalence and incidence of HCV infection among Vietnam heroin users with recent onset of injection. Clatts MC, Colon-Lopez V, le Giang M, Goldsamt LA, J Urban Health 2010 87 278 291 10.1007/s11524-009-9417-9 20041309
30. Behavioral interventions for HIV-positive and HCV-positive drug users. Strathdee SA, Patterson TL, AIDS Behav 2006 10 115 130 10.1007/s10461-005-9055-5 16463006
31. Incarceration experiences among a community-recruited sample of injection drug users in Bangkok, Thailand. Hayashi K, Milloy MJ, Fairbairn N, Kaplan K, Suwannawong P, Lai C, Wood E, Kerr T, BMC Publ Health 2009 9 492 10.1186/1471-2458-9-492
32. Opiate versus psychostimulant addiction: the differences do matter. Badiani A, Belin D, Epstein D, Calu D, Shaham Y, Nat Rev Neurosci 2011 12 685 700 10.1038/nrn3104 21971065
33. Methadone maintenance as HIV risk reduction with street-recruited injecting drug users. Kwiatkowski CF, Booth RE, J Acquir Immune Defic Syndr 2001 26 483 489 11391170 (Pubitemid 32489029)
34. Sexual activity as a risk factor for hepatitis C. Terrault NA, Hepatology 2002 36 99 S105 12407582